For example, bone marrow mesenchymal stem cells (BMSCs) from DISH patients demonstrate stronger differentiation into osteoblasts compared to controls, with Galectin-3 and Wnt/β-catenin signaling implicated in this enhanced osteogenesis [17]. This evidence concerns the gene LGALS3 and diffuse idiopathic skeletal hyperostosis.